1. 557. Impact of Concomitant Hydroxychloroquine Use on Safety and Efficacy of Remdesivir in Moderate COVID-19 Patients. (31st December 2020) Authors: Arribas, Jose Ramon; Arribas, Jose Ramon; Sanyal, Arun J; Soriano, Alex; Chin, Bum Sik; Chin, Bum Sik; Kalimuddin, Shirin; Schreiber, Stefan; Elboudwarej, Emon; Tian, Yuan; Hyland, Robert H; SenGupta, Devi; Chokkalingam, Anand; Osinusi, Anu; Brainard, Diana M; Lübbert, Christoph; Lye, David Chien... Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0133 FILGOTINIB, A SELECTIVE JANUS KINASE 1 (JAK1) INHIBITOR, MODULATES DISEASE-ASSOCIATED CYTOKINES IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS. (June 2019) Authors: Taylor, Peter C.; Elboudwarej, Emon; Wanying, LI; Hawtin, Rachael E.; Liu, Jinfeng; Mirza, Amer M. Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hypomethylation within gene promoter regions and type 1 diabetes in discordant monozygotic twins. (April 2016) Authors: Elboudwarej, Emon; Cole, Michael; Briggs, Farren B.S.; Fouts, Alexandra; Fain, Pamela R.; Quach, Hong; Quach, Diana; Sinclair, Elizabeth; Criswell, Lindsey A.; Lane, Julie A.; Steck, Andrea K.; Barcellos, Lisa F.; Noble, Janelle A. Journal: Journal of autoimmunity Issue: Volume 68(2016) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hypomethylation within gene promoter regions and type 1 diabetes in discordant monozygotic twins. (April 2016) Authors: Elboudwarej, Emon; Cole, Michael; Briggs, Farren B.S.; Fouts, Alexandra; Fain, Pamela R.; Quach, Hong; Quach, Diana; Sinclair, Elizabeth; Criswell, Lindsey A.; Lane, Julie A.; Steck, Andrea K.; Barcellos, Lisa F.; Noble, Janelle A. Journal: Journal of autoimmunity Issue: Volume 68(2016) Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P215 Filgotinib, a janus kinase 1 selective inhibitor, modulates disease-associated cytokines in patients with active RA. (20th April 2020) Authors: Taylor, Peter C; Elboudwarej, Emon; Li, Wanying; Hawtin, Rachael E; Liu, Jinfeng; Mirza, Amer M Journal: Rheumatology Issue: Volume 59(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗